Rho Nutrition Explores Sale Valuing Liquid Supplements Maker at Over $500 Million

Rho Nutrition, a maker of liquid supplements and vitamins, is exploring a sale that could value the privately held company at more than $500 million, according to people familiar with the matter. The Miami-based company is working with investment bank Rothschild on the process, which is at an early stage. Rho expects to generate around $200 million in revenue this year, the sources said. Rho and Rothschild declined to comment. Deal activity in the vitamins, minerals and supplements sector is booming as consumers prioritize health and GLP-1 users turn to supplements to counter side effects of weight-loss medications, such as muscle mass loss. This year, Procter & Gamble agreed to buy vitamin maker Thorne for $3.8 billion, Unilever bought gummy brand Grüns, and Yellow Wood Partners agreed to acquire Nestle's mainstream vitamins business. Supplement industry veterans Ryan Bishop and George Padilla co-founded Rho in 2022. The company uses liposomes to shield nutrients from digestive destruction, which it says allows for better absorption than traditional vitamins.